[MO28] JSNM Oral 28:Drug discovery and development 4 | JSNM2025/JSNMT2025

Advanced Search

Session Details

[JSNM]Oral & PosterAnnual Scientific Meeting of the Japanese Society of Nuclear Medicine Program : 一般演題口演

JSNM Oral 28:Drug discovery and development 4

Sat. Nov 15, 2025 10:20 AM - 11:30 AM JST
Sat. Nov 15, 2025 1:20 AM - 2:30 AM UTC

Room 2（1F, Exhibition Hall 2 A, Kyoto International Exhibition Hall 'Miyako Messe'）

座長：水間　広（大阪公立大学大学院医学研究科健康長寿医科学講座）、上原　知也（千葉大学大学院薬学研究院）

[3-MO28-1]Development of novel SSTR2-targeted radioligands focused on albumin binding affinity

Takuma Yamane、Nobuki Kazuta、Kazuma Nakashima、Hiroyuki Watanabe、Masahiro Ono (Graduate school of pharmaceutical sciences, Kyoto University, Kyoto, Japan)

[3-MO28-2]Development of cholecystokinin 2 receptor-targeted radioligand containing albumin binder

Takahiro Yamamoto¹、Kazuma Nakashima²、Nobuki Kazuta²、Hiroyuki Watanabe²、Masahiro Ono² (1.Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan、2.Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan)

[3-MO28-3]Study on tumor accumulation of integrin α_vβ₃-targeted radioligand using linker technology

Nobuki Kazuta、Kazuma Nakashima、Hiroyuki Watanabe、Masahiro Ono (Graduate school of pharmaceutical sciences, Kyoto University, Kyoto, Japan)

[3-MO28-4]Development of novel radiolabeled heterodimer targeting PSMA and GRPR in prostate cancer

Shohei Tsuchihashi、Kazuma Nakashima、Hiroyuki Watanabe、Masahiro Ono (Graduate School of Pharmaceutical Sciences, Kyoto University)

[3-MO28-5]Development of novel nuclear medicine imaging agents targeting fatty acid synthase

Jundai Yamagata¹、Kakeru Sato^1,2、Yuna Hamada¹、Ryotaro Abe¹、Ririka Handa¹、Yuma Momose¹、Jianwei Yao¹、Taiga Watanabe¹、Asuka Mizutani¹、Masato Kobayashi¹、Keiichi Kawai^1,3 (1.Division of Health Sciences, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan、2.Department of Radiology, University of Fukui Hospital, Fukui, Japan、3.Biomedical Imaging Research Center, University of Fukui, Fukui, Japan)

[3-MO28-6]Precision medicine of²¹¹At-CD82 based on histopathology in a humanized AML mouse model

Songji Zhao¹、Miho Aoki¹、Jingmin Zhao²、Naoyuki Ukon¹、Ken-ichi Nishijima¹、Kohshin Washiyama¹、Kazuhiro Takahashi¹、Hiroshi Ito^1,2、Taro Tachibana³、Noboru Oriuchi¹、Takayuki Ikezoe⁴ (1.Advanced Clinical Research Center, Fukushima Global Medical Science Center, Fukushima Medical University、2.Fukushima Medical University, Fukushima, Japan、3.Cell Engineering Corporation, Osaka, Japan、4.Fukushima Medical University, Fukushima, Japan)

[3-MO28-7]Development of Novel Nuclear Medicine Imaging Agents Targeting Organic Cation Transporters

Ryotaro Abe¹、Kenni You¹、Ririka Handa¹、Taiga Watanabe¹、Jyundai Yamagata¹、Yuuna Hamada¹、Yuma Momose¹、Kakeru Sato^1,2、Asuka Mizutani¹、Keiichi Kawai^1,3、Masato Kobayashi¹ (1.Graduate School of Medicine and Health Sciences,Kanazawa University,Ishikawa,Japan、2.Department of Radiology, University of Fukui Hospital、3.University of Fukui High Energy Research Center,Fuki,Japan)

Back to Category List